Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
25.90
+2.06 (8.64%)
At close: Aug 4, 2026

SHA:688806 Statistics

Total Valuation

SHA:688806 has a market cap or net worth of CNY 11.93 billion. The enterprise value is 12.24 billion.

Market Cap11.93B
Enterprise Value 12.24B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

SHA:688806 has 460.55 million shares outstanding. The number of shares has increased by 144.15% in one year.

Current Share Class 460.55M
Shares Outstanding 460.55M
Shares Change (YoY) +144.15%
Shares Change (QoQ) +5.46%
Owned by Insiders (%) 21.71%
Owned by Institutions (%) 31.43%
Float 209.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 156.98
PB Ratio 434.24
P/TBV Ratio 1,100.10
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 161.14
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 28.39.

Current Ratio 1.66
Quick Ratio 1.27
Debt / Equity 28.39
Debt / EBITDA n/a
Debt / FCF -1.46
Interest Coverage -26.19

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -100.10%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count843
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 17,884,623

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:688806 had revenue of CNY 75.98 million and -520.98 million in losses. Loss per share was -1.33.

Revenue75.98M
Gross Profit 38.13M
Operating Income -507.21M
Pretax Income -521.15M
Net Income -520.98M
EBITDA -485.36M
EBIT -507.21M
Loss Per Share -1.33
Full Income Statement

Balance Sheet

The company has 475.30 million in cash and 779.97 million in debt, with a net cash position of -304.67 million or -0.66 per share.

Cash & Cash Equivalents 475.30M
Total Debt 779.97M
Net Cash -304.67M
Net Cash Per Share -0.66
Equity (Book Value) 27.47M
Book Value Per Share 0.04
Working Capital 282.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -509.44 million and capital expenditures -23.12 million, giving a free cash flow of -532.56 million.

Operating Cash Flow -509.44M
Capital Expenditures -23.12M
Depreciation & Amortization 21.85M
Net Borrowing 262.94M
Free Cash Flow -532.56M
FCF Per Share -1.16
Full Cash Flow Statement

Margins

Gross Margin 50.18%
Operating Margin -667.52%
Pretax Margin -685.87%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SHA:688806 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -144.15%
Shareholder Yield -144.15%
Earnings Yield -4.37%
FCF Yield -4.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SHA:688806 has an Altman Z-Score of -3.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.66
Piotroski F-Score 2